UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC. - FORM 10-Q

Attached files

file	filename
EX-32.2 - EXHIBIT 32.2 - UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC.	ex32_2.htm
EX-32.1 - EXHIBIT 32.1 - UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC.	ex32_1.htm
EX-31.2 - EXHIBIT 31.2 - UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC.	ex31_2.htm
EX-31.1 - EXHIBIT 31.1 - UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC.	ex31_1.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

þ		QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended July 5, 2020
o		TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission file number: 000-50081

UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC.

(Name of registrant as specified in its charter)

Nevada		65-1005398
(State or Other Jurisdiction of Organization)		(IRS Employer Identification Number)

1800 2nd Street, Suite 970

Sarasota, FL 34236

(Address of principal executive offices)

(941) 906-8580

(Issuer’s telephone number)

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes þ No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

	Large accelerated filer o	Accelerated filer o
	Non-accelerated filer þ	Smaller reporting company þ
	Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ

Securities registered under Section 12(b) of the Act: None.

As of August 1, 2020, the issuer had 3,412,185 shares of ordinary Common Stock, $0.001 par value, and 323,821 shares of Class B Common Stock, $0.001 par value, outstanding.

UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC.

Form 10-Q

Table of Contents

		Page

Cautionary Note Regarding Forward-Looking Statements		3

PART I. FINANCIAL INFORMATION

Item 1.	Financial Statements	4

	Consolidated Balance Sheets	4
	Consolidated Statements of Operations	5
	Consolidated Statements of Comprehensive Loss	6
	Consolidated Statements of Changes in Stockholders’ Equity	7
	Consolidated Statements of Cash Flows	8
	Notes to Consolidated Financial Statements	9

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	21

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	30

Item 4.	Controls and Procedures	30

PART II. OTHER INFORMATION

Item 1.	Legal Proceedings	31

Item 1A.	Risk Factors	31

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	31

Item 3.	Defaults Upon Senior Securities	31

Item 4.	Mine Safety Disclosures	31

Item 5.	Other Information	31

Item 6.	Exhibits	31

Signatures		32

Table of Contents

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Except for statements of historical fact, certain information contained herein constitutes forward-looking statements including, without limitation, statements containing the words “believes,” “anticipates,” “intends,” “expects,” and words of similar import, as well as all references to future results. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results or achievements of Uniroyal Global Engineered Products, Inc. to be materially different from any future results or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the following: risks involved in implementing our business strategy, our ability to obtain financing on acceptable terms, competition, our ability to manage growth, pricing and availability of equipment, materials and inventories, performance issues with suppliers, economic growth, the Company’s ability to successfully integrate acquired operations, currency fluctuations, risks of technological change, the effectiveness of cost-reduction plans, our dependence on key personnel, our ability to protect our intellectual property rights, risks of new technology and new products, and government regulation. All forward-looking statements are qualified in their entirety by this cautionary statement, and the Company undertakes no obligation to revise or update any such forward-looking statements to reflect events, developments or circumstances after the date hereof.

Table of Contents

PART 1 - FINANCIAL INFORMATION

Item 1 - Financial Statements

Uniroyal Global Engineered Products, Inc.

Consolidated Balance Sheets

	(Unaudited)

ASSETS	July 5, 2020 (1)			December 29, 2019
CURRENT ASSETS
Cash and cash equivalents	$	1,238,728		$	513,588
Accounts receivable, net		5,034,809			11,662,325
Inventories, net		19,643,221			19,116,542
Other current assets		657,133			930,015
Related party receivable		6,644			-
Total Current Assets		26,580,535			32,222,470

PROPERTY AND EQUIPMENT, NET		18,314,779			19,103,319
OPERATING LEASE RIGHT-OF-USE ASSETS		6,033,204			6,607,963

OTHER ASSETS
Intangible assets		3,158,492			3,263,781
Goodwill		1,079,175			1,079,175
Other long-term assets		3,825,999			3,489,313
Total Other Assets		8,063,666			7,832,269
TOTAL ASSETS	$	58,992,184		$	65,766,021

LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Checks issued in excess of bank balance	$	208,428		$	332,141
Lines of credit		15,404,849			20,530,773
Current maturities of long-term debt		1,391,323			1,497,160
Current maturities of finance lease liabilities		17,816			106,253
Accounts payable		9,722,614			9,232,119
Accrued expenses and other liabilities		5,894,036			3,890,367
Related party obligation		241,194			608,517
Current portion of postretirement benefit liability - health and life		155,803			155,803
Total Current Liabilities		33,036,063			36,353,133

LONG-TERM LIABILITIES
Long-term debt, less current portion		2,655,375			3,378,458
Finance lease liabilities, less current portion		-			6,397
Operating lease liabilities		5,624,640			6,106,568
Related party lease financing obligation		2,577,406			2,646,970
Long-term debt to related parties		2,990,655			3,190,655
Postretirement benefit liability - health and life, less current portion		2,579,920			2,592,023
Other long-term liabilities		672,288			715,308
Total Long-Term Liabilities		17,100,284			18,636,379
Total Liabilities		50,136,347			54,989,512

STOCKHOLDERS' EQUITY
Preferred units, Series A UEP Holdings, LLC, 200,000 units issued and outstanding ($100 issue price)		617,571			617,571
Preferred units, Series B UEP Holdings, LLC, 150,000 units issued and outstanding ($100 issue price)		463,179			463,179
Preferred stock, Uniroyal Global (Europe) Limited, 50 shares issued and outstanding ($1.51 stated value)		75			75
Common stock, 95,000,000 shares authorized ($.001 par value) 3,736,006 shares issued and outstanding as of July 5, 2020 and December 29, 2019		3,736			18,680
Additional paid-in capital		35,290,590			35,275,646
Accumulated deficit		(25,873,959	)		(24,301,203	)
Accumulated other comprehensive loss		(1,645,355	)		(1,297,439	)
Total Stockholders' Equity		8,855,837			10,776,509
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	58,992,184		$	65,766,021

(1)	The amounts in common stock and additional paid-in capital were adjusted to reflect the one-for-five reverse stock split ("reverse stock split") as of February 24, 2020, the effective date of the reverse stock split. See Note 1 for additional information.

See accompanying notes to the consolidated financial statements.

Table of Contents

Uniroyal Global Engineered Products, Inc.

Consolidated Statements of Operations

(Unaudited)

	Three Months Ended						Six Months Ended

	July 5, 2020			June 30, 2019 (1)			July 5, 2020			June 30, 2019 (1)

NET SALES	$	7,216,371		$	24,095,783		$	28,356,495		$	49,489,643

COST OF GOODS SOLD		7,506,718			19,883,392			24,816,260			40,963,050

Gross Profit (Loss)		(290,347	)		4,212,391			3,540,235			8,526,593

OPERATING EXPENSES:
Selling		507,133			1,183,803			1,499,580			2,286,841
General and administrative		1,272,808			1,449,060			2,876,525			2,959,860
Research and development		157,655			447,754			506,057			924,718
Other operating expenses		-			-			-			343,003
OPERATING EXPENSES		1,937,596			3,080,617			4,882,162			6,514,422

Operating Income (Loss)		(2,227,943	)		1,131,774			(1,341,927	)		2,012,171

OTHER INCOME (EXPENSE):
Interest and other debt related expense		(380,834	)		(523,218	)		(848,317	)		(1,037,514	)
Funding from Paycheck Protection Program		2,183,676			-			2,183,676			-
Other income (expense)		(80,281	)		(224,950	)		(271,170	)		3,183
Net Other Income (Expense)		1,722,561			(748,168	)		1,064,189			(1,034,331	)

INCOME (LOSS) BEFORE TAX PROVISION		(505,382	)		383,606			(277,738	)		977,840

TAX PROVISION (BENEFIT)		(240,193	)		20,559			(292,823	)		(18,309	)

NET INCOME (LOSS)		(265,189	)		363,047			15,085			996,149

Preferred stock dividend		(795,006	)		(779,946	)		(1,587,841	)		(1,562,490	)

NET LOSS ALLOCABLE TO COMMON SHAREHOLDERS	$	(1,060,195	)	$	(416,899	)	$	(1,572,756	)	$	(566,341	)

LOSS PER COMMON SHARE:
Basic	$	(0.28	)	$	(0.11	)	$	(0.42	)	$	(0.15	)
Diluted	$	(0.28	)	$	(0.11	)	$	(0.42	)	$	(0.15	)
WEIGHTED AVERAGE SHARES OUTSTANDING:
Basic		3,736,006			3,736,951			3,736,006			3,737,479
Diluted		3,736,006			3,736,951			3,736,006			3,737,479

(1)	Share and per share amounts for the three and six months ended June 30, 2019 have been restated to reflect the one-for-five reverse stock split that became effective on February 24, 2020. See Note 1 for additional information.

See accompanying notes to the consolidated financial statements.

Table of Contents

Uniroyal Global Engineered Products, Inc.

Consolidated Statements of Comprehensive Loss

(Unaudited)

	Three Months Ended						Six Months Ended

	July 5, 2020			June 30, 2019			July 5, 2020			June 30, 2019

NET INCOME (LOSS)	$	(265,189	)	$	363,047		$	15,085		$	996,149

OTHER COMPREHENSIVE INCOME (LOSS):
Minimum benefit liability adjustment		-			(73,617	)		-			(147,234	)
Foreign currency translation adjustment		90,661			(254,674	)		(347,916	)		18,447
OTHER COMPREHENSIVE INCOME (LOSS)		90,661			(328,291	)		(347,916	)		(128,787	)

COMPREHENSIVE INCOME (LOSS)		(174,528	)		34,756			(332,831	)		867,362

Preferred stock dividend		(795,006	)		(779,946	)		(1,587,841	)		(1,562,490	)

COMPREHENSIVE LOSS TO COMMON SHAREHOLDERS	$	(969,534	)	$	(745,190	)	$	(1,920,672	)	$	(695,128	)

See accompanying notes to the consolidated financial statements.

Table of Contents

Uniroyal Global Engineered Products, Inc.

Consolidated Statements of Changes in Stockholders' Equity

(Unaudited)

	UEPH Series A				UEPH Series B				UGEL Preferred				Common Stock						Additional Paid In			Accumulated			Accumulated Other Comprehensive				Total Stockholders'
	Units		Amount		Units		Amount		Shares		Amount		Shares (1)			Amount (1)			Capital (1)			Deficit			Loss				Equity
For the Three Months Ended
June 30, 2019
Balance March 31, 2019		200,000	$	617,571		150,000	$	463,179		50	$	75		3,738,006		$	18,690		$	35,288,936		$	(22,285,572	)	$	(503,141	)	$	13,599,738
Net income		-		-		-		-		-		-		-			-			-			363,047			-			363,047
Other comprehensive loss		-		-		-		-		-		-		-			-			-			-			(328,291	)		(328,291	)
Treasury shares purchased at cost and retired		-		-		-		-		-		-		(2,000	)		(10	)		(13,290	)		-			-			(13,300	)
Preferred stock dividend		-		-		-		-		-		-		-			-			-			(779,946	)		-			(779,946	)
Balance June 30, 2019		200,000	$	617,571		150,000	$	463,179		50	$	75		3,736,006		$	18,680		$	35,275,646		$	(22,702,471	)	$	(831,432	)	$	12,841,248


For the Three Months Ended
July 5, 2020
Balance April 5, 2020		200,000	$	617,571		150,000	$	463,179		50	$	75		3,736,006		$	3,736		$	35,290,590		$	(24,813,764	)	$	(1,736,016	)	$	9,825,371
Net loss		-		-		-		-		-		-		-			-			-			(265,189	)		-			(265,189	)
Other comprehensive income		-		-		-		-		-		-		-			-			-			-			90,661			90,661
Preferred stock dividend		-		-		-		-		-		-		-			-			-			(795,006	)		-			(795,006	)
Balance July 5, 2020		200,000	$	617,571		150,000	$	463,179		50	$	75		3,736,006		$	3,736		$	35,290,590		$	(25,873,959	)	$	(1,645,355	)	$	8,855,837


For the Six Months Ended
June 30, 2019
Balance December 30, 2018		200,000	$	617,571		150,000	$	463,179		50	$	75		3,738,006		$	18,690		$	35,244,770		$	(22,136,130	)	$	(702,645	)	$	13,505,510
Net income		-		-		-		-		-		-		-			-			-			996,149			-			996,149
Other comprehensive loss		-		-		-		-		-		-		-			-			-			-			(128,787	)		(128,787	)
Stock-based compensation expense		-		-		-		-		-		-		-			-			44,166			-			-			44,166
Treasury shares purchased at cost and retired		-		-		-		-		-		-		(2,000	)		(10	)		(13,290	)		-			-			(13,300	)
Preferred stock dividend		-		-		-		-		-		-		-			-			-			(1,562,490	)		-			(1,562,490	)
Balance June 30, 2019		200,000	$	617,571		150,000	$	463,179		50	$	75		3,736,006		$	18,680		$	35,275,646		$	(22,702,471	)	$	(831,432	)	$	12,841,248


For the Six Months Ended
July 5, 2020
Balance December 29, 2019		200,000	$	617,571		150,000	$	463,179		50	$	75		3,736,006		$	18,680		$	35,275,646		$	(24,301,203	)	$	(1,297,439	)	$	10,776,509
Net income		-		-		-		-		-		-		-			-			-			15,085			-			15,085
Other comprehensive loss		-		-		-		-		-		-		-			-			-			-			(347,916	)		(347,916	)
Preferred stock dividend		-		-		-		-		-		-		-			-			-			(1,587,841	)		-			(1,587,841	)
Adjustment for a 1-for-5 reverse stock split		-		-		-		-		-		-		-			(14,944	)		14,944			-			-			-
Balance July 5, 2020		200,000	$	617,571		150,000	$	463,179		50	$	75		3,736,006		$	3,736		$	35,290,590		$	(25,873,959	)	$	(1,645,355	)	$	8,855,837

(1)

The number of shares of common stock reflect the one-for-five reverse stock split that became effective on February 24, 2020. The amounts in common stock and additional paid-in capital were adjusted as of the effective date of the one-for five reverse stock split. See Note 1 for additional information.

See accompanying notes to the consolidated financial statements.

Table of Contents

Uniroyal Global Engineered Products, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

	Six Months Ended

CASH FLOWS FROM OPERATING ACTIVITIES	July 5, 2020			June 30, 2019

Net income	$	15,085		$	996,149
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation		1,171,125			1,187,029
Stock-based compensation expense		-			44,166
Amortization of intangible assets		7,500			9,167
Loss on disposal of property and equipment		3,871			65,542
Noncash postemployment health and life benefit		-			(147,234	)
Noncash funding from Paycheck Protection Program		(2,183,676	)		-
Noncash lease adjustment		44,018			(49,250	)
Changes in assets and liabilities:
Accounts receivable		6,316,255			(1,719,059	)
Inventories		(906,058	)		(447,340	)
Other current assets		240,913			188,017
Related party receivable		(6,644	)		(8,845	)
Other long-term assets		(302,194	)		57,572
Accounts payable		807,418			370,722
Accrued expenses and other liabilities		565,255			275,278
Postretirement benefit liability - health and life		(12,103	)		(12,738	)
Other long-term liabilities		(8,082	)		(3,703	)
Cash provided by operating activities		5,752,683			805,473

CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures		(870,264	)		(738,944	)
Payments on life insurance policies		(49,346	)		(87,699	)
Cash used in investing activities		(919,610	)		(826,643	)

CASH FLOWS FROM FINANCING ACTIVITIES
Net change in checks issued in excess of bank balance		(123,713	)		(89,598	)
Net advances (payments) on lines of credit		(4,685,592	)		1,879,227
Payments on long-term debt		(766,025	)		(643,870	)
Proceeds from issuance of long-term debt		2,217,500			193,454
Payments on finance lease liabilities		(90,417	)		(203,710	)
Proceeds from related party obligations		200,000			200,000
Payments on related party obligations		(836,887	)		(49,555	)
Payment of preferred stock dividends		-			(1,560,822	)
Purchase and retirement of treasury stock		-			(13,300	)
Cash used in financing activities		(4,085,134	)		(288,174	)
Net change in cash and cash equivalents		747,939			(309,344	)
Cash and cash equivalents - beginning of period		513,588			1,028,841
Effects of currency translation on cash and cash equivalents		(22,799	)		4,701

CASH AND CASH EQUIVALENTS - END OF PERIOD	$	1,238,728		$	724,198

See Note 2 for noncash transactions and supplemental disclosure of cash flow information.

See accompanying notes to the consolidated financial statements.

Table of Contents

UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC.

Notes to Consolidated Financial Statements

July 5, 2020

(Unaudited)

Basis of Presentation

The accompanying unaudited interim consolidated financial statements have been prepared based upon U.S. Securities and Exchange Commission rules that permit reduced disclosure for interim periods. Therefore, they do not include all information and footnote disclosures necessary for a complete presentation of Uniroyal Global Engineered Products, Inc.’s financial position, results of operations and cash flows, in conformity with generally accepted accounting principles. Uniroyal Global Engineered Products, Inc. (the “Company,” “Uniroyal Global,” “we,” or “us”) filed audited consolidated financial statements as of and for the fiscal years ended December 29, 2019 and December 30, 2018 which included all information and notes necessary for such complete presentation in conjunction with its 2019 Annual Report on Form 10-K.

The results of operations for the interim period ended July 5, 2020 are not necessarily indicative of the results to be expected for any future period or the entire fiscal year. These interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended December 29, 2019, which are contained in the Company’s 2019 Annual Report on Form 10-K.

The Company owns all of the ownership interests in Uniroyal Engineered Products, LLC (“Uniroyal”) and its holding company UEP Holdings, LLC (“UEPH”), a U.S. manufacturer of textured coatings, and all of the ordinary common stock of Uniroyal Global (Europe) Limited (“UGEL”) formerly known as Engineered Products Acquisition Limited (“EPAL”), the holding company for Uniroyal Global Limited (“UGL”) formerly Wardle Storeys (Earby) Limited (“Wardle Storeys”), a European manufacturer of textured coatings and polymer films.

The Company and its subsidiaries use a 52/53-week fiscal year ending on the Sunday nearest to December 31. The current year ending January 3, 2021 is a 53-week year whereas the prior year ended December 29, 2019 was a 52-week year. The Company’s U.K. subsidiaries use the calendar year end of December 31. The activity of the U.K. subsidiaries that occurs on the days that do not coincide with the Company’s year-end is not material. The three months ended July 5, 2020 and June 30, 2019 were both 13-week periods while the six months ended July 5, 2020 was a 27-week period and the six months ended June 30, 2019 was a 26-week period.

The accompanying unaudited interim consolidated financial statements contain all adjustments (consisting of normal recurring items) which are, in the opinion of management, necessary for a fair presentation of the Company’s financial position as of July 5, 2020 and the results of operations, comprehensive loss and cash flows for the interim periods ended July 5, 2020 and June 30, 2019.

The unaudited interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company uses the U.S. dollar as the reporting currency for financial reporting. The financial position and results of operations of the Company’s U.K.-based operations are measured using the British Pound Sterling as the functional currency. See Note 4, Foreign Currency Translation.

For purposes of comparability, certain reclassifications have been made to amounts previously reported to conform with the current period presentation.

One-for-Five Reverse Stock Split

On January 27, 2020, the Company announced a one-for-five reverse stock split (“reverse stock split”) on its common stock that became effective on February 24, 2020. The amounts in common stock and additional paid-in capital were adjusted as of the effective date to reflect the reverse stock split. Share and per share amounts for the three and six months ended June 30, 2019 have been restated to give effect to the reverse stock split.

Table of Contents

Coronavirus (COVID-19)

Subsequent to year-end 2019, the World Health Organization declared the novel coronavirus (“COVID-19”) outbreak a public health emergency. There have been mandates from international, federal, state and local authorities requiring forced closures of various schools, businesses and other facilities and organizations. These forced closures have negatively impacted the Company’s business. Primarily due to the negative impact that COVID-19 is having on the global economy, the Company began to experience a decline in sales during the latter part of March 2020. In order to mitigate the effect of the decrease in revenue, the Company is managing its costs, which included initially reducing staff at its manufacturing facilities with production at one-third capacity at the U.S. facility and the entire production staff furloughed at the U.K. facility since late March. During June 2020, the Company had some employees return to work as its U.K. facility started limited production of vinyl products based on orders it was receiving from its customers. As incoming orders increase, the Company is bringing back additional production workers.

Additionally, the Company has applied for loans under programs offered by the governmental agencies in the United States and in the United Kingdom and is exploring options for other supplementary cash flow opportunities to provide further liquidity. During the second quarter of 2020, the Company received $2,217,500 in funds from Oregon Community Bank (formerly McFarland State Bank) through the Paycheck Protection Program (“PPP”) administered by the U.S. Small Business Administration (“SBA”) under the recently enacted Coronavirus Aid, Relief, and Economic Security Act (“the CARES Act”).

The loan matures on April 13, 2022 and bears an interest rate of 1.0%. The Company is required to make monthly payments of principal and interest beginning November 13, 2020 based on the amount that is outstanding on October 13, 2020 in order to fully amortize the loan by April 13, 2022. The loan may be prepaid by the Company at any time prior to maturity with no prepayment penalties.

All or a portion of the loan may be forgiven by the SBA for costs the Company incurs for payroll, rent, utilities and all other allowable expenses during the 24-week period beginning April 13, 2020. The Company intends to use all proceeds from the loan to maintain payroll and make payments for lease, utility and other allowable expenses. Included in the accompanying consolidated statements of operations for the three and six months ended July 5, 2020 was $2,183,676 of loan forgiveness that the Company expects to receive from the SBA. Although the Company has not been legally released from this amount of the loan, management concluded that there was reasonable assurance that the Company had substantially met the terms for forgiveness and therefore recognized this amount as income as a component of other income (expense). As of July 5, 2020, the remaining balance of the loan ($33,824) was expected to be recognized as forgiven debt during the third quarter of 2020.

Additionally during the second quarter of 2020, the Company recorded reimbursed costs of approximately $1,086,000 under the Coronavirus Job Retention Scheme (“CJRS”) set up by the U.K. government to help employers pay the wages of those employees who would otherwise have been laid off during the coronavirus outbreak but under the CJRS were furloughed instead. This program reimbursed the Company for 80% of the compensation expense plus national insurance and certain benefits paid to the furloughed employees, resulting in lower salary expense for the Company. While the employees were on furlough, the compensation paid to them was limited to the amount reimbursed by the CJRS. The Company recorded the reimbursed amounts as offsets to the related expense categories.

While the closures and limitations on movement, domestically and internationally, are expected to be temporary due to the COVID-19 outbreak, the duration of the supply chain disruption and related financial impact cannot be estimated at this time. Should the closures continue for an extended period of time or should the effects of the coronavirus continue to spread, the impact could have a material adverse effect on the Company’s financial position, results of operations and cash flows which may require that the Company obtain additional financing.

The payment of dividends for the six months ended July 5, 2020 and the three months ended December 29, 2019 was deferred to preserve cash and provide additional liquidity. As of July 5, 2020 and December 29, 2019, accrued dividends of $2,386,812 and $788,599, respectively, were included in accrued expenses and other liabilities in the accompanying consolidated balance sheets.

Table of Contents

Noncash Transactions and Supplemental Disclosure of Cash Flow Information

During the three and six months ended July 5, 2020, the Company recorded funding from the Paycheck Protection Program of $2,183,676, which is the amount of debt forgiveness that it expects to receive for the loan it made through the Paycheck Protection Program. Although the Company has not been legally released from this amount of the loan, management concluded that there was reasonable assurance that the Company had substantially met the terms for forgiveness, including using all proceeds from the loan for eligible costs (as defined under the Paycheck Protection Program).

During the six months ended June 30, 2019, the Company entered into several equipment financing obligations with fair values of $460,900, which are accounted for as capital assets. The fair values were added to property and equipment and a corresponding amount to long-term debt or related party lease financing obligation.

The Company adopted Accounting Standards Update (“ASU”) No. 2016-02, “Leases” on December 31, 2018. Under this new standard, the Company was required to record on its balance sheet previously unrecorded operating leases based on the present value of remaining lease payments. Per this new standard, the Company recorded operating lease right-of-use (“ROU”) assets and operating lease liabilities of $6,911,550 on its consolidated balance sheet as of December 31, 2018.

The following is supplemental disclosure of cash paid for the six months ended:

	July 5, 2020		June 30, 2019

Interest	$	903,299	$	984,956

Fair Value of Financial Instruments

The Company’s short-term financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable and lines of credit. The Company adjusts the carrying value of financial instruments denominated in other currencies such as cash, accounts receivable, accounts payable and lines of credit using the appropriate exchange rates at the balance sheet date. The Company believes that the carrying values of these short-term financial instruments approximate their estimated fair values.

The fair value of the Company’s long-term debt is estimated based on current rates for similar instruments with the same remaining maturities. In determining the current interest rates for similar instruments, the Company takes into account its risk of nonperformance. The Company believes that the carrying value of its long-term debt approximates its estimated fair value.

The Company uses foreign currency exchange contracts which are recorded at their estimated fair values in the accompanying consolidated balance sheets. The fair values of the currency exchange contracts are based upon observable market transactions of spot and forward rates.

For the six months ended July 5, 2020, there have been no changes in the application of valuation methods applied to similar assets and liabilities.

Foreign Currency Translation

The financial position and results of operations of the Company’s foreign subsidiaries are measured using the local currency as the functional currency. Assets and liabilities of operations denominated in foreign currencies are translated into U.S. dollars at exchange rates in effect at the balance sheet date, while the capital accounts are translated at the historical rate for the date they were recognized. Revenues and expenses are translated at the weighted average exchange rates during the reporting period. The resulting translation gains and losses on assets and liabilities are recorded in accumulated other comprehensive loss and are excluded from net income until realized through a sale or liquidation of the investment. Transaction gains and losses generated from the remeasurement of assets and liabilities denominated in currencies other than the functional currency of the Company’s foreign operations are included in other income (expense) in the accompanying consolidated statements of operations.

Table of Contents

Inventories

Inventories consist of the following:

	July 5, 2020			December 29, 2019

Raw materials	$	5,733,224		$	5,430,125
Work-in-process		4,359,423			4,677,987
Finished goods		11,522,070			10,922,947
		21,614,717			21,031,059
Less: Allowance for inventory obsolescence		(1,971,496	)		(1,914,517	)

Total Inventories, net	$	19,643,221		$	19,116,542

Other Long-term Assets

Other long-term assets consist of the following:

	July 5, 2020		December 29, 2019

Deferred tax asset, net	$	2,984,720	$	2,694,550
Other		841,279		794,763

Total Other Long-term Assets	$	3,825,999	$	3,489,313

Other Long-term Liabilities

Other long-term liabilities consist of the following:

	July 5, 2020		December 29, 2019

Deferred tax liability	$	666,925	$	709,945
Other		5,363		5,363

Total Other Long-term Liabilities	$	672,288	$	715,308

Lines of Credit

The Company’s Uniroyal subsidiary has available a $20,000,000 revolving line of credit financing agreement with Wells Fargo Capital Finance, LLC (“Uniroyal Line of Credit”), which matures on June 15, 2023. Interest is payable monthly at the Eurodollar rate plus 2.25% or Wells Fargo Capital Finance, LLC's prime rate at the Company's election on outstanding balances up to $6,000,000 and prime rate on amounts in excess of $6,000,000. Borrowings on the line of credit are subject to the underlying borrowing base specified in the agreement. The underlying borrowing base is currently determined based upon eligible accounts receivable, inventories and equipment. The line of credit is secured by substantially all of Uniroyal's assets and includes certain financial and restrictive covenants. The Company was in compliance with these covenants as of July 5, 2020.

The outstanding balance on the Uniroyal Line of Credit was $10,644,236 and $10,328,913 as of July 5, 2020 and December 29, 2019, respectively. The Company has classified the outstanding balance on this line of credit within current liabilities in the accompanying consolidated balance sheets. Based upon eligible accounts receivable, inventories and equipment at July 5, 2020, the Uniroyal Line of Credit provided additional availability of approximately $507,000 and, combined with its total cash balance of $881,428, Uniroyal had liquidity of approximately $1.4 million as of July 5, 2020.

Table of Contents

The Company’s UGL subsidiary has available a £10,500,000 (approximately $13.1 million) revolving line of credit financing agreement with Lloyds Bank Commercial Finance Limited (“UGL Line of Credit”), which is subject to a six-month notice by either party. The line has several tranches based on currency or underlying security. Interest is payable monthly at the base rate (U.K. LIBOR or Lloyds Bank Base Rate as published) plus 1.95% to 2.45% depending on the tranche. Borrowings on the line of credit are subject to the underlying borrowing base specified in the agreement. The underlying borrowing base is currently determined based upon eligible accounts receivable and inventories. The line of credit is secured by substantially all of the subsidiary's assets and includes certain financial and restrictive covenants. The Company was in compliance with these covenants as of July 5, 2020.

The outstanding balance on the UGL Line of Credit was £3,822,401 and £7,787,002 ($4,760,613 and $10,201,860) as of July 5, 2020 and December 29, 2019, respectively. The Company has classified the outstanding balance on this line of credit within current liabilities in the accompanying consolidated balance sheets. Based upon eligible accounts receivable and inventories at July 5, 2020, the UGL Line of Credit provided additional availability of approximately $1.3 million and, combined with its total cash balance of $334,243, UGL had liquidity of approximately $1.6 million as of July 5, 2020.

Long-term Debt

Long-term debt consists of the following:

	Interest Rate	July 5, 2020			December 29, 2019

Wells Fargo Capital Finance, LLC	Prime	$	916,418		$	1,099,700
Kennet Equipment Leasing Limited	10.90%		110,599			238,514
Regents Capital Corporation	6.20%-7.24%		839,234			994,830
De Lage Landen Financial Services	7.35%		28,194			42,793
Ford Motor Credit	4.31%		13,979			18,713
BB&T Equipment Finance Corporation	4.02%-5.12%		564,393			671,704
Crown Credit Company	7.06%		10,458			11,626
Lloyds Bank Commercial Finance Limited	3.95%		1,310,118			1,519,556
Lloyds Bank Commercial Finance Limited	4.23%		50,600			60,971
Lloyds Bank Commercial Finance Limited	LIBOR + 3.50%		168,881			217,211
Oregon Community Bank	1.00%		33,824			-
			4,046,698			4,875,618
Less: Current portion			(1,391,323	)		(1,497,160	)
Long-term Portion		$	2,655,375		$	3,378,458

10.

Related Party Obligations

Long-term debt to related parties consists of the following:

	Interest Rate	July 5, 2020		December 29, 2019

Senior subordinated promissory note	9.25%	$	2,000,000	$	2,000,000
Senior secured promissory note	10.00%		765,655		765,655
Subordinated secured promissory note	8.00%		225,000		225,000
Subordinated secured promissory note	8.00%		-		200,000
			2,990,655		3,190,655
Less: Current portion			-		-
Long-term Portion		$	2,990,655	$	3,190,655

Table of Contents

The above notes were amended on March 20, 2020 to change the maturity dates to January 15, 2022. No other terms of the notes were changed. The $200,000 note, which was outstanding since January 2019, was repaid in March 2020.

The Company has a lease financing obligation under which it leases its main U.S. manufacturing facility and certain other property from a related party lessor entity, owned by the Company’s majority shareholder. The lease financing obligation accrues interest at 14.95% and currently requires monthly principal and interest payments of $45,533, which are adjusted annually based on the consumer price index. The lease financing obligation matures on October 31, 2033. The Company has security deposits aggregating $267,500 held by the lessor entity.

The lease financing obligation consists of the following:

	July 5, 2020			December 29, 2019

Related party lease financing obligation	$	2,718,600		$	2,780,487
Less: Current portion		(141,194	)		(133,517	)

Long-term Portion	$	2,577,406		$	2,646,970

The long-term portion of the lease financing obligation is shown in the accompanying consolidated balance sheets as related party lease financing obligation. The current portion of the lease financing obligation and the remaining balance of related party short-term subordinated secured promissory notes are combined and are shown in current liabilities as related party obligation which consists of the following:

	July 5, 2020		December 29, 2019

Current portion of related party lease financing obligation	$	141,194	$	133,517

Related party subordinated secured promissory note		100,000		350,000

Related party subordinated secured promissory note		-		125,000

Related Party Obligation	$	241,194	$	608,517

The related party subordinated secured promissory notes are at a rate of 10%. During the three months ended April 5, 2020, the Company’s majority shareholder advanced $200,000 to the Company, which the Company repaid within the same period.

11.

Leases

The Company has operating leases for equipment and office facilities and finance leases for equipment. These leases expire at various dates from July 2020 through March 2039. Operating leases are included in operating lease right-of-use assets, accrued expenses and other liabilities, and operating lease liabilities in the accompanying consolidated balance sheets. Finance lease right-of-use assets are included in property and equipment, current maturities of finance lease liabilities, and finance lease liabilities, less current portion in the accompanying consolidated balance sheets.

The components of lease expense for the three months ended July 5, 2020 and June 30, 2019 are as follows:

	Three Months Ended
	July 5, 2020		June 30, 2019

Operating lease expense	$	246,055	$	292,140

Finance lease expense:
Amortization of right-of-use assets	$	33,847	$	37,407
Interest on lease liabilities		511		4,799
Total finance lease expense	$	34,358	$	42,206

Table of Contents

The components of lease expense for the six months ended July 5, 2020 and June 30, 2019 are as follows:

	Six Months Ended
	July 5, 2020		June 30, 2019

Operating lease expense	$	496,976	$	564,204

Finance lease expense:
Amortization of right-of-use assets	$	69,629	$	77,305
Interest on lease liabilities		1,738		11,036
Total finance lease expense	$	71,367	$	88,341

Cash paid for amounts included in the measurement of lease liabilities for the three months ended July 5, 2020 and June 30, 2019 are as follows:

	Three Months Ended
	July 5, 2020		June 30, 2019

Operating cash flows from operating leases	$	181,115	$	252,220
Operating cash flows from finance leases	$	511	$	4,799
Financing cash flows from finance leases	$	4,536	$	101,859

Cash paid for amounts included in the measurement of lease liabilities for the six months ended July 5, 2020 and June 30, 2019 are as follows:

	Six Months Ended
	July 5, 2020		June 30, 2019

Operating cash flows from operating leases	$	420,347	$	497,813
Operating cash flows from finance leases	$	1,738	$	11,036
Financing cash flows from finance leases	$	90,417	$	203,710

Right-of-use assets obtained in exchange for lease obligations for the three months ended July 5, 2020 and June 30, 2019 are as follows:

	Three Months Ended
	July 5, 2020		June 30, 2019

Operating leases	$	-	$	248,176
Finance leases	$	-	$	-

Right-of-use assets obtained in exchange for lease obligations for the six months ended July 5, 2020 and June 30, 2019 are as follows:

	Six Months Ended
	July 5, 2020		June 30, 2019

Operating leases	$	-	$	287,828
Finance leases	$	-	$	-

Table of Contents

Supplemental balance sheet and other information related to operating leases are as follows:

	July 5, 2020			December 29, 2019
Operating leases:
Operating lease right-of-use assets	$	6,033,204		$	6,607,963
Accrued expenses and other liabilities	$	448,062		$	497,225
Operating lease liabilities		5,624,640			6,106,568
Total operating lease liabilities	$	6,072,702		$	6,603,793
Weighted average remaining lease term		15.6 years			15.7 years
Weighted average discount rate		7.20	%		7.16	%

Supplemental balance sheet and other information related to finance leases are as follows:

	July 5, 2020			December 29, 2019
Finance leases:
Property and equipment, net	$	1,172,599		$	1,305,798
Current maturities of finance lease liabilities	$	17,816		$	106,253
Finance lease liabilities, less current portion		-			6,397
Total finance lease liabilities	$	17,816		$	112,650
Weighted average remaining lease term		0.8 year			0.5 year
Weighted average discount rate		11.07	%		6.06	%

Maturities of operating and finance lease liabilities as of July 5, 2020 are as follows:

	Operating Leases		Finance Leases
Due in one year or less	$	865,286	$	18,529
Due after one year through two years		812,284		-
Due after two years through three years		762,537		-
Due after three years through four years		517,267		-
Due after four years through five years		485,537		-
Thereafter		7,374,341		-
Total lease payments		10,817,252		18,529
Less: Interest		(4,744,550)		(713)
Total	$	6,072,702	$	17,816

12.

Accumulated Other Comprehensive Loss

The changes in accumulated other comprehensive loss were as follows:

	Minimum Benefit Liability Adjustments		Foreign Currency Translation Adjustment			Total

Balance at December 29, 2019	$	5,694	$	(1,303,133	)	$	(1,297,439	)

Other comprehensive loss before reclassifications		-		(347,916	)		(347,916	)

Balance at July 5, 2020	$	5,694	$	(1,651,049	)	$	(1,645,355	)

Table of Contents

13.

Stock Based Compensation

On June 25, 2015, the Company’s stockholders approved the adoption of the 2015 Stock Option Plan. This plan provides for the granting of options to purchase the Company’s common stock to employees and directors. The options granted are subject to a vesting schedule as set forth in each individual option agreement. Each option expires on the tenth anniversary of its date of grant unless an earlier termination date is provided in the grant agreement. The maximum aggregate number of shares of common stock that may be optioned and sold under the plan shall be 6% of the shares outstanding on the date of grant. The shares that may be optioned under the plan may be authorized but unissued or may be treasury shares. Compensation expense is recognized on a straight-line basis over a three-year vesting period from date of grant.

Stock option activity for the six months ended July 5, 2020 and June 30, 2019 is as follows:

	Stock Options
	Total			Weighted Average Exercise Price		Exercis- able			Weighted Average Exercise Price		Non- Vested			Weighted Average Exercise Price
Outstanding at December 30, 2018 (1)		189,300		$	13.98		166,867		$	13.46		22,433		$	17.85
Granted		-			-		-			-		-			-
Vested (1)		-			-		22,433			17.85		(22,433	)		17.85
Exercised		-			-		-			-		-			-
Forfeited or cancelled (1)		(3,000	)		13.85		(3,000	)		13.85		-			-
Outstanding at June 30, 2019 (1)		186,300		$	13.99		186,300		$	13.99		-		$	-

Outstanding at December 29, 2019		151,800		$	14.02		151,800		$	14.02		-		$	-
Granted		-			-		-			-		-			-
Vested		-			-		-			-		-			-
Exercised		-			-		-			-		-			-
Forfeited or cancelled		-			-		-			-		-			-
Outstanding at July 5, 2020		151,800		$	14.02		151,800		$	14.02		-		$	-

Aggregate Intrinsic Value June 30, 2019	$	-				$	-				$	-

Aggregate Intrinsic Value July 5, 2020	$	-				$	-				$	-

(1)	The number and weighted average exercise price of options have been restated to reflect a one-for-five reverse stock split that became effective on February 24, 2020. See Note 1 for additional information.

As of July 5, 2020 and June 30, 2019, there was no aggregate intrinsic value of the options outstanding because the options’ weighted average exercise prices of $14.02 and $13.99 per share, respectively, were greater than the average market prices of the common shares.

There was no option expense recognized for the three months ended July 5, 2020 and June 30, 2019, and for the six months ended July 5, 2020. Option expense recognized was $44,166 for the six months ended June 30, 2019. As of July 5, 2020, there was no unrecognized compensation cost related to the options granted under the 2015 Stock Option Plan.

Table of Contents

14.

Recent Accounting Standards

On August 28, 2018, the Financial Accounting Standards Board issued a new standard, ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement.” The new standard modifies the disclosure requirements on fair value measurements in Topic 820, “Fair Value Measurement.” Certain requirements were removed such as the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, certain requirements were modified and certain disclosures were added such as the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period. The Company adopted this standard on December 30, 2019. Since this standard only revises disclosure requirements, the adoption of this standard for the year ending January 3, 2021 will not have a significant effect on the Company’s consolidated financial position, results of operations and cash flows.

On December 18, 2019, the Financial Accounting Standards Board issued a new standard, ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This new guidance simplifies the accounting for income taxes by removing certain exceptions such as the exception to the incremental approach for intraperiod tax allocation when there is a loss from continuing operations and income/gain from other items; and the exception to the general methodology for calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year. The new guidance also simplifies the accounting for income taxes under certain circumstances such as requiring that an entity recognize a franchise tax that is partially based on income as an income-based tax and account for any incremental amount incurred as a non-income-based tax; requiring that an entity evaluate when a step up in the tax basis of goodwill should be considered part of a business combination in which the book goodwill was originally recognized and when it should be considered a separate transaction; and requiring that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. This standard will be effective for the Company on January 4, 2021. The Company is currently evaluating the effects this standard will have, if any, on its consolidated financial position, results of operations and cash flows.

Table of Contents

15.

Loss per Common Share

The following table sets forth the computation of loss per common share - basic and loss per common share – diluted for the three and six months ended July 5, 2020 and June 30, 2019:

	Three Months Ended						Six Months Ended
	July 5, 2020			June 30, 2019 (1)			July 5, 2020			June 30, 2019 (1)
Numerator
Net loss allocable to common shareholders	$	(1,060,195	)	$	(416,899	)	$	(1,572,756	)	$	(566,341	)

Denominator
Denominator for basic earnings per share - weighted average shares outstanding		3,736,006			3,736,951			3,736,006			3,737,479
Weighted average effect of dilutive securities		-			-			-			-
Denominator for dilutive earnings per share - weighted average shares outstanding		3,736,006			3,736,951			3,736,006			3,737,479

Basic and Diluted Net Loss Per Share
Net loss allocable to common shareholders	$	(0.28	)	$	(0.11	)	$	(0.42	)	$	(0.15	)
Effect of dilutive securities		-			-			-			-
Net loss allocable to common shareholders	$	(0.28	)	$	(0.11	)	$	(0.42	)	$	(0.15	)

(1)

Share and per share amounts for the three and six months ended June 30, 2019 have been restated to reflect a one-for-five reverse stock split that became effective on February 24, 2020. See Note 1 for additional information.

Due to the net loss allocable to common shareholders for the three and six months ended July 5, 2020 and the three and six months ended June 30, 2019, the calculations of basic and diluted loss per share were the same since including options to purchase shares of the Company’s common stock in the calculations of diluted loss per share would have been anti-dilutive. However, if diluted earnings per share had been reported for the three and six months ended July 5, 2020 and the three and six months ended June 30, 2019, the calculations would have excluded options to purchase 151,800 and 186,300 shares of common stock, respectively, because the options’ weighted average exercise prices of $14.02 and $13.99 per share, respectively, were greater than the average market prices of the common shares.

Table of Contents

16.

Revenue

The Company recognizes revenue and related accounts receivable when obligations under the terms of a contract with a customer are satisfied, which includes the control of products transferring to the customer. For Uniroyal, this generally occurs when products are shipped and, for UGL, this generally occurs when the customer accepts delivery either at the Company’s U.K. facility or at a mutually agreed upon location. Revenue is measured as the amount of consideration the Company expects to receive in exchange for products transferred to the customer.

The following table sets forth revenue disaggregated by the Company’s automotive and industrial sectors for the three and six months ended July 5, 2020 and June 30, 2019:

	Three Months Ended				Six Months Ended
	July 5, 2020		June 30, 2019		July 5, 2020		June 30, 2019
Revenue by product sector:
Automotive	$	2,503,581	$	15,821,277	$	15,801,641	$	32,300,670
Industrial		4,712,790		8,274,506		12,554,854		17,188,973
Total Revenue	$	7,216,371	$	24,095,783	$	28,356,495	$	49,489,643

The following table sets forth revenue disaggregated by the geographic locations of the Company’s customers for the three and six months ended July 5, 2020 and June 30, 2019:

	Three Months Ended				Six Months Ended
	July 5, 2020		June 30, 2019		July 5, 2020		June 30, 2019
Revenue by customer location:
North America	$	5,403,849	$	11,902,854	$	16,152,046	$	24,314,538
Europe		1,615,182		10,782,170		10,609,681		22,606,670
Asia		146,421		1,310,157		1,328,280		2,416,023
Other		50,919		100,602		266,488		152,412
Total Revenue	$	7,216,371	$	24,095,783	$	28,356,495	$	49,489,643

17.

Restructuring Expenses

In order to increase operating efficiencies and decrease costs, the Company developed a plan to restructure the operations and the management team of its foreign operations facility located in Earby, England. As part of the restructuring, during the quarter ended March 31, 2019, the Company entered into settlement agreements with certain members of that facility’s management team which terminated their continuing service. The Company recorded a charge of $343,003 for the cost of these agreements which is included in other operating expenses in the accompanying consolidated statements of operations for the six months ended June 30, 2019.

18.

Subsequent Events

The Company has evaluated subsequent events occurring through the date that the financial statements were available to be issued for events requiring recording or disclosure in the July 5, 2020 consolidated financial statements. Subsequent to July 5, 2020, the Company approached its U.K. automotive customers and other stakeholders to provide additional working capital to meet various short-term cash needs. As of July 29, 2020, it received approximately $1.5 million in loans from these sources and an additional $800,000 loan from its principal shareholder.

Table of Contents

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Business Description

We are a leading provider of manufactured vinyl coated fabrics. Our best-known brand, Naugahyde, is the product of many improvements on a rubber-coated fabric developed a century ago in Naugatuck, Connecticut. We design, manufacture and market a wide selection of vinyl coated fabric products under a portfolio of recognized brand names. We believe that our business has continued to be a leading supplier in its marketplace because of our ability to provide specialized materials with performance characteristics customized to the end-user specifications, complemented by technical and customer support for the use of our products in manufacturing.

Our vinyl coated fabric products have undergone considerable evolution and today are distinguished by superior performance in a wide variety of applications as alternatives to leather, cloth and other synthetic fabric coverings. Our standard product lines consist of more than 600 SKUs with combinations of colors, textures, patterns and other properties. Our products are differentiated by unique protective top finishes and transfer print capabilities. Additional process capabilities include embossing grains and patterns, and rotogravure printing, which imparts five color character prints and non-registered prints, lamination and panel cutting.

Our vinyl coated fabric products have various high-performance characteristics and capabilities. They are durable, stain resistant, easily processed, more cost-effective and better performing than traditional leather or fabric coverings. Our products are frequently used in applications that require rigorous performance characteristics such as automotive and non-automotive transportation, certain indoor/outdoor furniture, commercial and hospitality seating, healthcare facilities and athletic equipment. We manufacture materials in a wide range of colors and textures. They can be hand or machine sewn, laminated to an underlying structure, thermoformed to cover various substrates or made into a variety of shapes for diverse end-uses. We are a long-established supplier to the global automotive industry and manufacture products for interior soft trim components from floor to headliner, which are produced to meet specific component production requirements such as cut and sew, vacuum forming/covering, compression molding, and high frequency welding. Some products are supplied with micro perforations, which are necessary on most compression molding processes. Materials can also be combined with polyurethane or polypropylene foam laminated by either flame or hot melt adhesive for seating, fascia and door applications.

Products are developed and marketed based upon the performance characteristics required by end-users. For example, for recreational products used outdoors, such as boats, personal watercraft, golf carts and snowmobiles, a product designed primarily for water-based durability and weatherability is used. We also manufacture a line of products called BeautyGard^®, with water-based topcoats that contain agents to protect against bacterial and fungal micro-organisms and can withstand repeated cleaning, a necessity in the restaurant and health care industries. These topcoats are environmentally friendlier than solvent-based topcoats. The line is widely used in hospitals and other healthcare facilities. Flame and smoke retardant vinyl coated fabrics are used for a variety of commercial and institutional furniture applications, including hospitals, restaurants and residential care centers and seats for school buses, trains and aircraft.

We currently conduct our operations in manufacturing facilities that are located in Stoughton, Wisconsin and Earby, England.

Critical Accounting Policies and Estimates

The preparation of our consolidated financial statements and related disclosures in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and judgments that affect our reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. On an on-going basis, we evaluate our estimates and assumptions based upon historical experience and various other factors and circumstances. We believe that our estimates and assumptions are reasonable under the circumstances; however, actual results may vary from these estimates and assumptions under different future circumstances. For further discussion of our significant accounting policies, refer to Note 1 – “Summary of Significant Accounting Policies” to the consolidated financial statements and “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies, Judgments and Estimates” in our Annual Report on Form 10-K for the fiscal year ended December 29, 2019.

Table of Contents

Recent Accounting Pronouncements

See Note 14 – “Recent Accounting Standards” to the consolidated financial statements for a discussion of recent accounting guidance.

Overview:

Our Earby, England operation’s functional currency is the British Pound Sterling (“Pound Sterling”) and has sales and purchases transactions that are denominated in currencies other than the Pound Sterling, principally the Euro. Approximately 25% of the Company’s global revenues and 27% of its global raw material purchases are derived from these Euro transactions.

The average year-to-date exchange rate for the Pound Sterling to the U.S. Dollar was approximately 2.5% lower and the average exchange rate for the Euro to the Pound Sterling was approximately 0.5% higher in 2020 compared to 2019. These exchange rate changes had the effect of decreasing net sales by approximately $308,000 for the six months ended July 5, 2020. The overall currency effect on the Company’s net loss was a positive amount of approximately $14,000 for the six months ended July 5, 2020.

The U.K. exit from the European Union on January 31, 2020, commonly referred to as Brexit, has caused, and may continue to cause, uncertainty in the global markets. Political and regulatory responses to the withdrawal are still developing, and we are in the process of assessing the impact that the withdrawal may have on our business as more information becomes available. Any impact from Brexit on our business and operations over the long term will depend, in part, on the outcome of tariff, tax treaties, trade, regulatory, and other negotiations the U.K. conducts.

Table of Contents

All or a portion of the loan may be forgiven by the SBA for costs the Company incurs for payroll, rent, utilities and other allowable expenses during the 24-week period beginning April 13, 2020. The Company intends to use all proceeds from the loan to maintain payroll and make payments for lease, utility and other allowable expenses. Included in the accompanying consolidated statements of operations for the three and six months ended July 5, 2020 was $2,183,676 of loan forgiveness that the Company expects to receive from the SBA. Although the Company has not been legally released from this amount of the loan, management concluded that there was reasonable assurance that the Company had substantially met the terms for forgiveness and therefore recognized this amount as income. As of July 5, 2020, the remaining balance of the loan ($33,824) was expected to be recognized as forgiven debt during the third quarter of 2020.

Three Months Ended July 5, 2020 Compared to the Three Months Ended June 30, 2019

The following table sets forth, for the three months ended July 5, 2020 (“three months 2020”) and June 30, 2019 (“three months 2019”), certain operational data including their respective percentage of net sales:

	Three Months Ended
	July 5, 2020				June 30, 2019				Change			% Change

Net Sales	$	7,216,371		100.0%	$	24,095,783		100.0%	$	(16,879,412	)	-70.1%
Cost of Goods Sold		7,506,718		104.0%		19,883,392		82.5%		(12,376,674	)	-62.2%
Gross Profit (Loss)		(290,347	)	-4.0%		4,212,391		17.5%		(4,502,738	)	<-100%
Operating Expenses:
Selling		507,133		7.0%		1,183,803		4.9%		(676,670	)	-57.2%
General and administrative		1,272,808		17.6%		1,449,060		6.0%		(176,252		-12.2%
Research and development		157,655		2.2%		447,754		1.9%		(290,099	)	-64.8%
Total Operating Expenses		1,937,596		26.9%		3,080,617		12.8%		(1,143,021	)	-37.1%
Operating Income (Loss)		(2,227,943	)	-30.9%		1,131,774		4.7%		(3,359,717	)	<-100%
Interest expense		(380,834	)	-5.3%		(523,218	)	-2.2%		142,384		-27.2%
Funding from Paycheck Protection Program		2,183,676		30.3%		-		0.0%		2,183,676		-
Other expense		(80,281	)	-1.1%		(224,950	)	-0.9%		144,669		-64.3%
Income (Loss) before Tax Provision		(505,382	)	-7.0%		383,606		1.6%		(888,988	)	<-100%
Tax provision (benefit)		(240,193	)	-3.3%		20,559		0.1%		(260,752	)	<-100%
Net Income (Loss)		(265,189	)	-3.7%		363,047		1.5%		(628,236	)	<-100%
Preferred stock dividend		(795,006	)	-11.0%		(779,946	)	-3.2%		(15,060	)	1.9%
Net Loss Allocable to Common Shareholders	$	(1,060,195	)	-14.7%	$	(416,899	)	-1.7%	$	(643,296	)	>100%

Table of Contents

Revenue:

Total revenue for the three months 2020 decreased $16,879,412 or 70.1% to $7,216,371 from $24,095,783 for the three months 2019. The currency effect on total revenue was a positive amount of approximately $15,000.

For the three months 2020 compared to the three months 2019, U.S. automotive sales decreased 78.9% and European automotive sales decreased 85.1% (excluding the currency adjustment). This significant decrease was principally due to the COVID-19 pandemic, where most of the Company’s customers in this market and the OEMs of the automobiles that use the Company’s products, shut down production lines or their entire production facilities at the end of the first quarter 2020 and continued into the second quarter 2020 as the pandemic continued. The automotive market was improving at the end of the second quarter as most of the customers and OEMs were restarting their production facilities. The Company’s sales activity increased significantly in June 2020 as compared to the prior two months. However, they had not yet reached the run-rate of the period prior to the onset of COVID-19.

Additionally, sales for the industrial sector decreased 43.0% (the same as before the currency effect) primarily due to a decline in the U.S. contract market. The negative impact of COVID-19 on the global economy was a major factor in the overall decline in sales.

Also impacting 2020 revenue to a lesser degree, the Company in August 2019, decommissioned and shut down equipment in the U.K. that manufactured calender product for both the automotive and industrial market. The Company had built sufficient inventory of this product to service its customers for several months after the shutdown. Shortly before the shutdown, the Company entered into agreements with another company to provide some of the calender film it originally produced. Once the film was further processed by the Company, it was able to continue offering certain products to one of its customers. During the three months 2020, the Company sold $64,744 of calender product principally using the purchased film compared to $1,441,559 for the three months 2019. Of these amounts, all were in the automotive market for the three months 2020 and $1,053,890 were in the automotive market for the three months 2019.

Gross Profit (Loss):

Total gross loss for the three months 2020 was $290,347 compared to gross profit of $4,212,391 for the three months 2019, a decrease of $4,502,738. The gross loss percentage was -4.0% of sales for the three months 2020 compared to the gross profit percentage of 17.5% for the three months 2019. The negative amount and percentage for the three months 2020 were primarily due to the impact of COVID-19. Despite reducing manufacturing costs in the three months 2020, which included approximately $934,000 of costs reimbursed through the CJRS for the salaries of furloughed employees, total revenue for the quarter was not enough to offset fixed costs which were disproportionately high relative to total sales. The currency effect on gross loss was a positive amount of approximately $66,000.

Operating Expenses:

Selling expenses for the three months 2020 decreased $676,670 or 57.2% to $507,133 from $1,183,803 for the three months 2019. As previously mentioned, the Company operates in an industry and market that was significantly impacted by the COVID-19 pandemic. As a result, sales were significantly less than the prior year due to plant closures of many of its customers. To respond to the lower sales activity, selling expenses such as travel and entertainment were lower in 2020. In addition, most of the staff in the U.K. were on furlough and receiving 80% of their normal wages. The Company was reimbursed approximately $56,000 for these wages through the CJRS resulting in lower salary expense. Also contributing to the lower selling expenses in 2020 was the 2019 closure of the calender product line and the elimination of its applicable employment and commission costs. There was a favorable currency effect that slightly contributed to the decrease in selling expenses also.

General and administrative expenses for the three months 2020 decreased $176,252 or 12.2% to $1,272,808 from $1,449,060 for the three months 2019. This decrease was primarily attributable to the COVID-19 pandemic and lower employment related and other administrative costs, including wages of approximately $20,000 that were reimbursed through the CJRS. Partially offsetting the decrease was the unfavorable currency effect of $43,000.

Research and development expenses for the three months 2020 decreased $290,099 or 64.8% to $157,655 from $447,754 for the three months 2019. The decrease was principally decreased activities attributable to the COVID-19 pandemic and lower development costs for new trials and wages of approximately $76,000 that were reimbursed through the CJRS. There was an unfavorable currency effect that slightly offset the decrease in research and development expenses.

Operating Income (Loss):

Operating loss for the three months 2020 was $2,227,943 compared to operating income of $1,131,774 for the three months 2019, a decrease of $3,359,717. The decrease was due to the decline in gross profit, which was partially offset by the decrease in operating expenses both a result of COVID-19. The operating loss percentage was -30.9% of sales for the three months 2020 compared to the operating income percentage of 4.7% for the three months 2019.

Table of Contents

Interest Expense:

Interest expense for the three months 2020 decreased $142,384 or 27.2% to $380,834 from $523,218 for the three months 2019. The decrease was primarily due to lower interest rates on LIBOR and prime during the three months 2020 and debt repayments compared to the three months 2019.

Funding from Paycheck Protection Program:

For the three months 2020, the $2,183,676 funding from the PPP is the amount of debt forgiveness that the Company expects to receive from the SBA under the CARES Act for eligible costs incurred by the Company as of July 5, 2020, as previously discussed.

Other Expense:

Other expense for the three months 2020 was $80,281 compared to $224,950 for the three months 2019. Included in other expense are the currency gains and losses recognized on foreign currency transactions and the change in the fair value of financial assets and liabilities that are denominated in Euros as these currencies fluctuated during the period. Also included in other expense are gains and losses from the change in fair values on the Company’s foreign currency exchange contracts.

Tax Provision (Benefit):

The Company files income tax returns in the United States as a C-Corporation, and in several state jurisdictions and in the United Kingdom. The Company’s U.S. operating subsidiary, Uniroyal, is a limited liability company (LLC) for federal and state income tax purposes and as such, its income, losses, and credits are allocated to its members. The Company made the acquisition of Uniroyal through UEPH, a limited liability company, which issued preferred ownership interests to the sellers that provide for quarterly dividends. Uniroyal’s taxable income is allocated entirely to UEPH as its sole member and since it is a pass-through entity, this income less the dividends paid to the sellers of Uniroyal is reported on the Company’s tax return. The taxable income applicable to the dividends for the preferred ownership interests is reported to the sellers who report it on their respective individual tax returns.

The Company does not have a history of repatriating a significant portion of its foreign cash. However, if it decided to repatriate these foreign amounts to fund U.S. operations, the Company would not be required to pay any additional U.S. tax related to these amounts since the Company previously recorded a one-time transition tax on deemed repatriation of deferred foreign income.

The tax benefit for the three months 2020 was $240,193 compared to a tax provision of $20,559 for the three months 2019. Both the tax benefit for the three months 2020 and the tax provision for the three months 2019 were principally attributable to the results of the U.S. operations.

Preferred Stock Dividend:

The terms of the acquisitions in November 2014 resulted in the issuance of preferred ownership units/stock of UEP Holdings, LLC and UGEL (formerly EPAL) to the sellers. These preferred units have carried quarterly dividend requirements on a total value of $55,000,000 at rates ranging from 5.0% to 8.0%. The dividend rate on the Series B UEP Holdings preferred units which started at 5.5% increases by 0.5% on the anniversary of the issuance up to a maximum of 8.0%. The payment of dividends for the three months ended July 5, 2020, April 5, 2020 and December 29, 2019 was deferred to preserve cash and provide additional liquidity. As of July 5, 2020 and December 29, 2019, accrued dividends of $2,386,812 and $788,599, respectively, were included in accrued expenses and other liabilities in the accompanying consolidated balance sheets.

Table of Contents

Six Months Ended July 5, 2020 Compared to the Six Months Ended June 30, 2019

The following table sets forth, for the six months ended July 5, 2020 (“six months 2020”) and June 30, 2019 (“six months 2019”), certain operational data including their respective percentage of net sales:

	Six Months Ended
	July 5, 2020				June 30, 2019				Change			% Change

Net Sales	$	28,356,495		100.0%	$	49,489,643		100.0%	$	(21,133,148	)	-42.7%
Cost of Goods Sold		24,816,260		87.5%		40,963,050		82.8%		(16,146,790	)	-39.4%
Gross Profit		3,540,235		12.5%		8,526,593		17.2%		(4,986,358	)	-58.5%
Operating Expenses:
Selling		1,499,580		5.3%		2,286,841		4.6%		(787,261	)	-34.4%
General and administrative		2,876,525		10.1%		2,959,860		6.0%		(83,335	)	-2.8%
Research and development		506,057		1.8%		924,718		1.9%		(418,661	)	-45.3%
Other operating expenses		-		0.0%		343,003		0.7%		(343,003	)	-100.0%
Total Operating Expenses		4,882,162		17.2%		6,514,422		13.2%		(1,632,260	)	-25.1%
Operating Income (Loss)		(1,341,927	)	-4.7%		2,012,171		4.1%		(3,354,098	)	<-100%
Interest expense		(848,317	)	-3.0%		(1,037,514	)	-2.1%		189,197		-18.2%
Funding from Paycheck Protection Program		2,183,676		7.7%		-		0.0%		2,183,676		-
Other income (expense)		(271,170	)	-1.0%		3,183		0.0%		(274,353	)	<-100%
Income (Loss) before Tax Provision		(277,738	)	-1.0%		977,840		2.0%		(1,255,578	)	<-100%
Tax benefit		(292,823	)	-1.0%		(18,309	)	0.0%		(274,514	)	>100%
Net Income		15,085		0.1%		996,149		2.0%		(981,064	)	-98.5%
Preferred stock dividend		(1,587,841	)	-5.6%		(1,562,490	)	-3.2%		(25,351	)	1.6%
Net Loss Allocable to Common Shareholders	$	(1,572,756	)	-5.5%	$	(566,341	)	-1.1%	$	(1,006,415	)	>100%

Revenue:

Total revenue for the six months 2020 decreased $21,133,148 or 42.7% to $28,356,495 from $49,489,643 for the six months 2019. The currency effect on total revenue was a negative amount of approximately $308,000.

For the six months 2020 compared to the six months 2019, U.S. automotive sales decreased 49.9% and European automotive sales decreased 50.4% (excluding the currency adjustment). This significant decrease was principally due to the COVID-19 pandemic, where most of the Company’s customers in this market and the OEMs of the automobiles that use the Company’s products, shut down production lines or their entire production facilities at the end of the first quarter 2020 and continued into the second quarter 2020 as the pandemic continued. The automotive market was improving at the end of the second quarter as most of the customers and OEMs were restarting their production facilities. The Company’s sales activity increased significantly in June 2020 as compared to the prior two months. However, they had not yet reached the run-rate of the period prior to the onset of COVID-19.

Additionally, sales for the industrial sector decreased 27.0% (26.8% before currency effect) primarily due to a decline in the U.S. contract market. The negative impact of COVID-19 on the global economy was a major factor in the overall decline in sales which principally began during the latter part of March 2020.

Also impacting 2020 revenue to a lesser degreee, the Company in August 2019, decommissioned and shut down equipment in the U.K. that manufactured calender product for both the automotive and industrial market. The Company had built sufficient inventory of this product to service its customers for several months after the shutdown. Shortly before the shutdown, the Company entered into agreements with another company to provide some of the calender film it originally produced. Once the film was further processed by the Company, it was able to continue offering certain products to one of its customers. During the six months 2020, the Company sold $745,882 of calender product principally using the purchased film compared to $2,821,250 for the six months 2019. Of these amounts, $691,351 and $1,986,529 were in the automotive market for the six months 2020 and 2019, respectively.

Table of Contents

Gross Profit:

Total gross profit for the six months 2020 decreased $4,986,358 or 58.5% to $3,540,235 from $8,526,593 for the six months 2019. The gross profit percentage was 12.5% of sales for the six months 2020 compared to 17.2% for the six months 2019. Gross profit amount and percentage were negatively impacted by the effect of COVID-19. Despite reducing manufacturing costs in the six months 2020, which included approximately $934,000 of costs reimbursed through the CJRS for the salaries of furloughed employees, fixed costs were disproportionately high relative to total sales. The decrease in gross profit included a negative net currency effect of $17,000.

Operating Expenses:

Selling expenses for the six months 2020 decreased $787,261 or 34.4% to $1,499,580 from $2,286,841 for the six months 2019. As previously mentioned, the Company operates in an industry and market that was significantly impacted by the COVID-19 pandemic. As a result, sales were significantly less than the prior year due to plant closures of many of its customers. To respond to the lower sales activity, selling expenses such as travel and entertainment were lower in 2020. In addition, most of the staff in the U.K. were on furlough and receiving 80% of their normal wages. The Company was reimbursed approximately $56,000 for these wages through the CJRS resulting in lower salary expense. Also contributing to the lower selling expenses in 2020 was the 2019 closure of the calender product line and the elimination of its applicable employment and commission costs. Additionally contributing to the decrease was the favorable currency effect of $16,000.

General and administrative expenses for the six months 2020 decreased $83,335 or 2.8% to $2,876,525 from $2,959,860 for the six months 2019. This decrease was primarily attributable to the COVID-19 pandemic and lower employment related and other administrative costs, including wages of approximately $20,000 that were reimbursed through the CJRS. Partially offsetting the decrease was the unfavorable currency effect of $9,000.

Research and development expenses for the six months 2020 decreased $418,661 or 45.3% to $506,057 from $924,718 for the six months 2019. The decrease was principally decreased activities attributable to the COVID-19 pandemic and lower development costs for new trials and wages of approximately $76,000 that were reimbursed through the CJRS. Partially offsetting the decrease was the unfavorable currency effect of $5,000.

There were no other operating expenses for the six months 2020 and $343,003 for 2019. The amount for 2019 was cost incurred by the Company as part of a restructuring plan to reduce inefficiencies at its U.K. facility.

Operating Income (Loss):

Operating loss for the six months 2020 was $1,341,927 compared to operating income of $2,012,171 for the six months 2019, a decrease of $3,354,098. The decrease was due to the decline in gross profit, which was partially offset by the decrease in operating expenses, which included the $343,003 non-recurring restructuring charge in 2019. The operating loss percentage was -4.7% of sales for the six months 2020 compared to the operating income percentage of 4.1% for the six months 2019.

Interest Expense:

Interest expense for the six months 2020 decreased $189,197 or 18.2% to $848,317 from $1,037,514 for the six months 2019. The decrease was primarily due to lower interest rates on LIBOR and prime during the six months 2020 and debt repayments compared to the six months 2019.

Funding from Paycheck Protection Program:

For the six months 2020, the $2,183,676 funding from the PPP is the amount of debt forgiveness that the Company expects to receive from the SBA under the CARES Act for eligible costs incurred by the Company as of July 5, 2020, as previously discussed.

Table of Contents

Other Income (Expense):

Other expense for the six months 2020 was $271,170 compared to other income of $3,183 for the six months 2019. Included in other income (expense) are the currency gains and losses recognized on foreign currency transactions and the change in the fair value of financial assets and liabilities that are denominated in Euros as these currencies fluctuated during the period. Also included in other income (expense) are gains and losses from the change in fair values on the Company’s foreign currency exchange contracts.

Tax Benefit:

The tax benefit for the six months 2020 was $292,823, principally attributable to the results of the U.S. operations, compared to $18,309 for the six months 2019, principally attributable to the results of the U.K. operations.

Preferred Stock Dividend:

The terms of the acquisitions in November 2014 resulted in the issuance of preferred ownership units/stock of UEP Holdings, LLC and UGEL (formerly EPAL) to the sellers. These preferred units have carried quarterly dividend requirements on a total value of $55,000,000 at rates ranging from 5.0% to 8.0%. The dividend rate on the Series B UEP Holdings preferred units which started at 5.5% increases by 0.5% on the anniversary of the issuance up to a maximum of 8.0%. The payment of dividends for the six months ended July 5, 2020 and the three months ended December 29, 2019 was deferred to preserve cash and provide additional liquidity. As of July 5, 2020 and December 29, 2019, accrued dividends of $2,386,812 and $788,599, respectively, were included in accrued expenses and other liabilities in the accompanying consolidated balance sheets.

Liquidity and Sources of Capital

Cash, as it is needed, is provided by using the Company’s lines of credit. These lines provide for a total borrowing commitment in excess of $33,000,000 subject to the underlying borrowing base specified in the agreements. Of the total outstanding borrowings of $15,404,849 at July 5, 2020, $10.8 million of the lines bears interest at LIBOR or the Eurodollar rate plus a range of 1.95% to 2.45%, depending on the underlying borrowing base and $4.6 million bears interest at the bank’s prime or base lending rate which was 3.25% at July 5, 2020. The lines provided additional availability of approximately $1.8 million and, combined with UEP’s and UGL’s total cash balances, liquidity was approximately $3.0 million at July 5, 2020. We plan to use this availability and cash provided by operating activities to finance our cash needs for the remaining months of fiscal 2020 and future periods. The balances due under the lines of credit are recorded as current liabilities on the consolidated balance sheets.

As a result of the COVID-19 pandemic, sales of the Company’s products are lower than expected. This has had a negative impact on the Company’s working capital which could affect its ability to borrow using the Company’s lines of credit. To increase its liquidity, as previously discussed, the Company has applied for loans under programs offered by the governmental agencies in the United States and in the United Kingdom. Early in the second quarter of 2020, the Company received $2,217,500 in funds through the Paycheck Protection Program administered by the United States Small Business Administration, of which $2,183,676 of this debt is expected to be forgiven as of July 5, 2020. In the U.K., the Company has also recorded £875,000 ($1,086,000) in funding available under the Coronavirus Job Retention Scheme which reimbursed the Company for the compensation expense paid to furloughed employees.

The Company continues to attempt to manage its operating costs to match the reduced sales volume. Although sales activities are increasing, this may not be sufficient to provide the funds needed particularly for the U.K. operations where the sales reduction was more significant. The Company is seeking additional funding through programs established by the U.K. government. There is no guarantee that the Company will be successful in obtaining this funding. The Company also approached its U.K. automotive customers and other stakeholders to provide additional working capital to meet various short-term cash needs. As of July 29, 2020, it received approximately $1.5 million in loans from these sources and an additional $800,000 loan from its principal shareholder.

Table of Contents

The ratio of current assets to current liabilities, including the amount due under our lines of credit, was 0.80 at July 5, 2020 and 0.89 at December 29, 2019.

Cash balances increased $747,939, before the effects of currency translation of $(22,799), to $1,238,728 at July 5, 2020 from $513,588 at December 29, 2019. Of the above noted amounts, $334,243 and $498,007 were held outside the U.S. by our foreign subsidiaries as of July 5, 2020 and December 29, 2019, respectively.

Cash provided by operations was $5,752,683 for the six months 2020 compared to $805,473 for the six months 2019. For the six months 2020, cash provided by operations was primarily due to changes in working capital of $7,017,139 and net income of $15,085 offset by adjustments for non-cash items of $(957,162) and changes in other assets and liabilities of $(322,379). For the six months 2019, cash provided by operations was primarily due to adjustments for non-cash items of $1,109,420, net income of $996,149 and changes in other assets and liabilities of $41,131 offset by changes in working capital of $(1,341,227).

Cash used in investing activities was $919,610 for the six months 2020 compared to $826,643 for the six months 2019. During 2020 and 2019, cash used in investing activities was principally for purchases of machinery and equipment at our manufacturing locations and payments made for company-owned key man life insurance premiums.

For the six months 2020, cash used in financing activities was $4,085,134 compared to $288,174 for the six months 2019. Impacting cash flows from financing activities for the six months 2020 and 2019 were net payments on lines of credit of $4,685,592 and net advances on lines of credit of $1,879,227, respectively. The changes in the lines of credit reflect the funding of working capital. There were no preferred dividend payments during the six months 2020 compared to $1,560,822 during the six months 2019, which impacted cash flows from financing activities. As previously stated, the dividends for the six months 2020 were deferred to preserve cash and provide additional liquidity. During the six months 2020, payments of $775,000 were made on subordinated secured promissory notes to our majority shareholder. There were no similar payments made during the six months 2019.

Our credit agreements contain customary affirmative and negative covenants. We were in compliance with our debt covenants as of July 5, 2020 and through the date of filing of this report.

We currently have several on-going capital projects that are important to our long-term strategic goals. Machinery and equipment will also be added as needed to increase capacity or enhance operating efficiencies in our manufacturing plants. We will use a combination of financing arrangements to provide the necessary capital. We believe that our existing resources, including cash on hand and our credit facilities, together with cash generated from operations and additional bank borrowings, will be sufficient to fund our cash flow requirements through at least the next twelve months. However, there can be no assurance that additional financing will be available on favorable terms, if at all.

We have no material off balance sheet arrangements.

Table of Contents

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Not applicable.

Item 4.

Controls and Procedures

The Company maintains “disclosure controls and procedures” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer, Chief Financial Officer, and Board of Directors, as appropriate, to allow timely decisions regarding required disclosures. In designing and evaluating our disclosure controls and procedures, management recognizes that disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired objectives, and we necessarily are required to apply our judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures.

Our management, including our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of July 5, 2020 and concluded that our disclosure controls and procedures were effective as of July 5, 2020.

Changes in Internal Controls over Financial Reporting

During the six months ended July 5, 2020, there were no changes in the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Table of Contents

PART II. OTHER INFORMATION

Item 1.

Legal Proceedings

None.

Item 1A.

Risk Factors

Not applicable.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

None.

Item 3.

Defaults Upon Senior Securities

None.

Item 4.

Mine Safety Disclosures

Not applicable.

Item 5.

Other Information

None.

Item 6.

Exhibits

(a)

Exhibits.

Exhibit No.		Description

31.1 *		Chief Executive Officer Certification Pursuant to Securities Exchange Act Rules 13a-14(a)
31.2 *		Chief Financial Officer Certification Pursuant to Securities Exchange Act Rules 13a-14(a)
32.1 *		Chief Executive Officer Certification Pursuant to 18 U.S.C. Section 1350
32.2 *		Chief Financial Officer Certification Pursuant to 18 U.S.C. Section 1350
101.INS * +		XBRL Instance Document
101.CAL * +		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF * +		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB * +		XBRL Taxonomy Extension Label Linkbase Document
101.PRE * +		XBRL Taxonomy Extension Presentation Linkbase Document
101.SCH * +		XBRL Taxonomy Extension Schema Document

_______________

*	Filed herewith.

+	In accordance with Rule 406T of Regulation S-T, this information is deemed not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

Table of Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC.


Dated: August 14, 2020	By:	/s/ Howard R. Curd
		Howard R. Curd Chief Executive Officer

Dated: August 14, 2020

By:

/s/ Edmund C. King

Edmund C. King

Chief Financial Officer

Attached files

Stock widget

Investing forum

UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC. Reports